Edition:
India

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

5.50USD
17 May 2019
Change (% chg)

$-0.12 (-2.14%)
Prev Close
$5.62
Open
$5.57
Day's High
$5.61
Day's Low
$5.42
Volume
254,057
Avg. Vol
327,802
52-wk High
$11.60
52-wk Low
$5.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 72.67 -0.619
FY 2018 Dec '18 59.85 -0.864
Sep '18 53.17 -0.457
Jun '18 48.79 -0.599
Mar '18 45.93 -0.482
FY 2017 Dec '17 90.56 0.328
Sep '17 41.28 -0.493
Jun '17 28.52 -0.527
Mar '17 20.86 -1.149
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 7 90.46 104.15 78.50 57.85
Quarter Ending Sep-19 7 94.89 108.06 80.55 54.11
Year Ending Dec-19 8 351.46 395.94 280.46 241.82
Year Ending Dec-20 9 365.97 463.15 262.10 181.94
Earnings (per share)
Quarter Ending Jun-19 7 -0.33 -0.10 -0.46 -0.53
Quarter Ending Sep-19 7 -0.28 -0.08 -0.45 -0.44
Year Ending Dec-19 8 -1.43 -0.56 -2.28 -1.14
Year Ending Dec-20 10 -0.66 0.38 -1.66 -0.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 14.63 -- --
EPS (TTM) % -46.08 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akebia Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -18.03 -16.73 17 --
13 Week -17.29 -19.72 30 --
26 Week -30.99 -33.97 25 --
52 Week -47.62 -50.17 32 --
YTD -0.54 -12.81 38 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 72.12%
# of Holders: 226
Total Shares Held: 84,996,968
3 Mo. Net Change: 3,235,223
# New Positions: 33
# Closed Positions: 26
# Increased Positions: 97
# Reduced Positions: 85
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.